April 1, 2020
The National Law Journal named New York partner Jane Love among its 2020 Health Care/Life Science Trailblazers. Love was recognized for her work representing “Novartis AG’s multiple sclerosis drug Gilenya in cases impacting patent owners and challengers across the pharmaceutical and biotech industries.” The report was published on April 1, 2020.
Jane Love’s practice spans four areas: (1) patent litigation, (2) Patent Office trial proceedings including inter partes reviews (IPRs), (3) strategic patent prosecution advice and (4) patent diligence in transactions. She has extensive experience in pharmaceutical and biologics patent issues, including Abbreviated New Drug Application (ANDA) litigation, Biologics Price Competition and Innovation Act of 2009 (BPCIA) biosimilar litigation issues, and PTO Inter Partes Reviews under the America Invents Act (AIA). She has coordinated global litigation of patents worldwide.